Market Cap (In EUR)
294.4 Billion
Revenue (In EUR)
54.31 Billion
Net Income (In EUR)
4.86 Billion
Avg. Volume
14.00
- Currency
- EUR
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0-190.72
- PE
- -
- EPS
- -
- Beta Value
- 0.5551325
- ISIN
- US00287Y1091
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Richard A. Gonzalez
- Employee Count
- -
- Website
- http://www.abbvie.com
- Ipo Date
- 2020-02-20
- Details
- AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
More Stocks
-
IL&FSTRANSIL&FS Transportation Networks Limited
IL&FSTRANS
-
FLSS
-
MTB-PJM&T Bank Corporation
MTB-PJ
-
7296F.C.C. Co., Ltd.
7296
-
5Y7A
-
3313
-
7551Weds Co., Ltd.
7551
-
EDAPEDAP TMS S.A.
EDAP